L. Chan et al., Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors, BIOORG MED, 10(13), 2000, pp. 1477-1480
Following the identification of first pass metabolism issues with our recen
tly described anti-HCMV compounds, the naphthyridines and isoquinolines, we
have designed a class of novel metabolically stable and orally bioavailabl
e anti-HCMV agents, the dihydroisoquinolines. (C) 2000 Elsevier Science Ltd
. All rights reserved.